| Literature DB >> 29340792 |
Guo-Guang Ma1, Guang-Wei Hao1, Xiao-Mei Yang1, Du-Ming Zhu1, Lan Liu1, Hua Liu1, Guo-Wei Tu2, Zhe Luo3.
Abstract
BACKGROUND: To evaluate the efficacy of using internal jugular vein variability (IJVV) as an index of fluid responsiveness in mechanically ventilated patients after cardiac surgery.Entities:
Keywords: Cardiac surgery; Fluid responsiveness; Inferior vena cava; Internal jugular veins; Stroke volume variation
Year: 2018 PMID: 29340792 PMCID: PMC5770347 DOI: 10.1186/s13613-017-0347-5
Source DB: PubMed Journal: Ann Intensive Care ISSN: 2110-5820 Impact factor: 6.925
Fig. 1Ultrasound probe position for IJV detection at the cricoid cartilage level (a). The patient is in the supine position at 30°. M-mode assessment of the antero-posterior diameter of the IJV in a responsive patient (b, a high variability of IJV diameter is seen) and in a non-responsive patient (c, lack of variation of the IJV diameter is seen) while on mechanical ventilation
Baseline characteristics of the patients (n = 70)
| Characteristic | |
|---|---|
| Age (years) | 61 ± 10 |
| Male sex, | 44 (62.86) |
| Body mass index (kg/m2) | 22 ± 3 |
| Left ventricular ejection fraction (%) | 50 |
| Cardiac surgery category, | |
| Valve | 37 (52.86) |
| CABG | 12 (17.14) |
| CABG + valve | 7 (10.00) |
| Aortic surgery | 9 (12.86) |
| Others | 5 (7.14) |
| Postoperative day, | |
| 62 (88.57%) | |
| | 8 (11.43%) |
| APACHE II scores | 9 ± 5 |
| EuroSCORE | 4 ± 2 |
| Tidal volume (mL) | 520 ± 28 |
| PEEP (cm H2O) | 5 |
| PaO2/FiO2 (mmHg) | 123 ± 57 |
| Lactate (mmol/L) | 3.23 ± 3.39 |
| Patients receiving norepinephrine, | 45 (64.29) |
| Patients receiving dobutamine, | 9 (12.86) |
| Dose of norepinephrine (μg kg−1 min−1) | 0.24 (0.15–0.35) |
| Dose of dobutamine (μg kg−1 min−1) | 0.33 (0.28–0.43) |
Values are expressed as mean ± SD, median (25–75% inter-quartile range) or number and frequency in %
CABG coronary artery bypass grafting, APACHE II acute physiology and chronic health evaluation, EuroSCORE European system for cardiac operative risk evaluation, PEEP positive end-expiratory pressure, PaO arterial partial pressure of oxygen, FiO inspiratory fraction of oxygen
Hemodynamic parameters measured in responders and non-responders
| HR (beats min−1) | |||
| Responders | 91 ± 20 | 89 ± 18 | 87 ± 14 |
| Non-responders | 88 ± 17 | 88 ± 17 | 87 ± 16 |
| SBP (mmHg) | |||
| Responders | 87 ± 19 | 95 ± 29 | 119 ± 26c |
| Non-responders | 111 ± 17a | 116 ± 19a | 112 ± 23 |
| DBP (mmHg) | |||
| Responders | 46 ± 8 | 53 ± 7b | 58 ± 8c |
| Non-responders | 55 ± 11a | 58 ± 9a | 54 ± 8a |
| MAP (mmHg) | |||
| Responders | 58 ± 10 | 67 ± 9b | 73 ± 11c |
| Non-responders | 71 ± 10a | 75 ± 10a | 70 ± 9 |
| CVP (mmHg) | |||
| Responders | 11 ± 4 | 11 ± 3 | 12 ± 3 |
| Non-responders | 12 ± 4 | 14 ± 4a,b | 13 ± 4 |
| CO (L/min) | |||
| Responders | 3.60 ± 1.54 | 4.68 ± 1.79b | 5.11 ± 2.15c |
| Non-responders | 4.17 ± 0.93 | 4.50 ± 1.17 | 4.69 ± 1.44 |
| SV (ml) | |||
| Responders | 39.87 ± 13.67 | 52.99 ± 16.22b | 58.72 ± 22.16c |
| Non-responders | 49.86 ± 17.71a | 53.52 ± 18.14 | 54.81 ± 16.53 |
| SVV (%) | |||
| Responders | 14.94 ± 1.85 | 10.34 ± 5.26b | 8.71 ± 4.59c |
| Non-responders | 9.49 ± 2.67a | 7.74 ± 4.83a | 7.03 ± 2.67c |
| IJVV (%) | |||
| Responders | 23.04 ± 16.76 | 9.88 ± 13.76b | 7.96 ± 8.72c |
| Non-responders | 9.90 ± 5.63a | 6.38 ± 2.37b | 5.73 ± 2.02c |
| IVCV (%) | |||
| Responders | 15.97 ± 4.08 | 8.98 ± 4.52b | 8.08 ± 7.70c |
| Non-responders | 8.78 ± 5.42a | 8.14 ± 4.94 | 6.41 ± 2.76c |
Values are expressed as mean ± SD
HR heart rate, BP, SBP systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial pressure, CVP central venous pressure, CO cardiac output, SV stroke volume, SVV stroke volume variation, IJVV internal jugular venous variability, IVCV inferior vena cava variability
T0 baseline, T1 after passive leg raising test, T2 after fluid expansion
aP < 0.05 non-responders versus responders
bP < 0.05 T1 versus T0
cP < 0.05 T2 versus T0
Fig. 2Pearson correlation analysis. (a, association between IJVV and SVV; b, association between IVCV and SVV)
Fig. 3Comparison of the areas under the ROC curves for the indicators used for predicting fluid responsiveness (a, dynamic indicators; and b, static indicators)
Diagnostic ability of the different indices of fluid responsiveness
| AUC (95% CI) | Optimal cutoff (%) | Sensitivity (%) | Specificity (%) | Youden index | Positive predictive value | Negative predictive value | Positive likelihood ratio | Negative likelihood ratio | |
|---|---|---|---|---|---|---|---|---|---|
| Dynamic indicators | |||||||||
| SVV | 0.97 (0.89–0.99) | 12.00 | 91.43 | 94.29 | 0.86 | 0.94 | 0.92 | 16.00 | 0.09 |
| PLR-ΔSV | 0.91 (0.82–0.97) | 12.84 | 100.00 | 82.86 | 0.83 | 0.85 | 1.00 | 5.83 | 0.00 |
| IJVV | 0.88 (0.78–0.94) | 12.99 | 91.43 | 82.86 | 0.74 | 0.84 | 0.91 | 5.33 | 0.10 |
| IVCV | 0.83 (0.72–0.91) | 13.39 | 85.71 | 85.71 | 0.71 | 0.86 | 0.86 | 6.00 | 0.17 |
| Static indicators | |||||||||
| CVP | 0.70 (0.57–0.80) | 11.00 | 60.00 | 77.14 | 0.37 | 0.72 | 0.66 | 2.63 | 0.52 |
| IVCmax | 0.53 (0.40–0.65) | 1.57 | 48.57 | 74.29 | 0.23 | 0.65 | 0.59 | 1.89 | 0.69 |
| IVCmin | 0.58 (0.46–0.70) | 1.40 | 54.29 | 74.29 | 0.29 | 0.68 | 0.62 | 2.11 | 0.62 |
| IJVmax | 0.55 (0.43–0.67) | 0.86 | 48.57 | 65.71 | 0.14 | 0.59 | 0.56 | 1.42 | 0.78 |
| IJVmin | 0.55 (0.43–0.67) | 0.64 | 51.43 | 80.00 | 0.31 | 0.72 | 0.62 | 2.57 | 0.61 |
AUC area under the receiver operating characteristic curve, CI confidence interval, SVV respiratory variation of stroke volume, PLR-∆SV the increase in stroke volume in response to a passive leg raising test, IJVV internal jugular venous variability, IVCV inferior vena cava variability, CVP central venous pressure, IVCmax the maximum inferior vena cava diameter, IVCmin the minimum inferior vena cava diameter, IJVmax the maximum internal jugular venous diameter, IJVmin the minimum internal jugular venous diameter